MYDA Advisors’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

MYDA Advisors’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,750	Closed	-$90K	–	141
2022 Q3	$90K	Hold	3,750	–	–	0.04%	139
2022 Q2	$74K	Hold	3,750	–	–	0.02%	168
2022 Q1	$135K	Sell	3,750 -500	-12%	-$18.6K	0.05%	162
2021 Q4	$190K	Sell	4,250 -1,654	-28%	-$99.2K	0.05%	205
2021 Q3	$420K	Buy	5,904 +625	+12%	+$71.1K	0.12%	169
2021 Q2	$697K	Buy	5,279 +279	+6%	+$34.9K	0.17%	154
2021 Q1	$670K	Buy	+5,000	New	+$634K	0.19%	151
2018 Q4	–	Sell	-250	Closed	-$80K	–	144
2018 Q3	$80K	Sell	250 -298	-54%	-$94.1K	0.04%	126
2018 Q2	$195K	Buy	+548	New	+$170K	0.09%	122

Other funds holding ASLN

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MYDA Advisors's ASLN Position: Q4 2022 in Review

MYDA Advisors sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q4 2022, closing a stake of 3,750 shares — an estimated $90K sold.

MYDA Advisors first reported a position in ASLN in Q2 2018 and held it in 9 quarters. The position peaked at $697K in Q2 2021. 24 funds tracked by Wall St. Rank hold ASLN as of Q4 2022.

MYDA Advisors reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q4 2022 after selling out during the quarter.
MYDA Advisors sold 3,750 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q4 2022, an estimated $90K.
MYDA Advisors first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q2 2018 and held it in 9 quarters.
MYDA Advisors's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $697K in Q2 2021.
24 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q4 2022.

Based on MYDA Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.